Application YC di Volumetric
Volumetric ha partecipato a Y Combinator nel batch Winter 2020 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Winter 2020
- Settore
- HealthcareIndustrial Bio
- Dimensione team
- 5
- Stato
- Acquired
- Lanciata
- 2020
Founder
Jordan MillerCo-Founder and President
Bagrat GrigoryanCo-Founder, COO
Cosa fa Volumetric
About Us Volumetric is a recognized world leader in building living multicellular tissues, with a focus on replicating discrete functions of the human body for basic mechanistic biology, laboratory testing and screening, and drug development. Founded in 2018 by Bagrat Grigoryan and Jordan Miller as a spin-out from Rice University, the full potential of our work is to build whole human organ replacements for patients, made from their own cells. Our Technology and Approach We have invented a suite of breakthrough 3D bioprinting technologies, featured on the cover of Science, that can build human tissue with complex blood vessel networks. We are leveraging this technology in the short term to build patient-specific tissues for drug safety and efficacy testing. Patient cells are taken from a biopsy, added to our proprietary 3D printed tissues, and then drug compounds are injected through the blood vessel network to mimic actual drug delivery in humans. Our vision is that our technology will provide rigorous, reproducible, and predictive outcomes for patients, resulting in drastically improved outcomes for diseases like cancer. More broadly, we see the full potential of our mission as being able to produce functional tissue and organ replacements for diseased or damaged vital organs in the body such as the lung, liver, pancreas, kidney, and heart.
Application YC di Volumetric, ricostruita
Domanda per Y Combinator
Volumetric, batch Winter 2020. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Volumetric
Build living multicellular human tissues
We build living human tissues with complex blood vessel networks using proprietary 3D bioprinting technology. Our product replicates discrete human organ functions for biology research, drug testing, and drug safety screening. We take patient cells from biopsies, add them to printed tissues, and deliver drugs through built-in vessels to mimic real human responses. Long term, we aim to replace diseased organs with functional, patient-specific tissues.
We are based in Houston, TX, and the company would remain there after YC.
Houston puts us close to Rice University where our technology started and provides access to biomedical and industrial bio partners. We're rooted here and it's where our team and ecosystem are strongest.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di Volumetric?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Volumetric (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Volumetric si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva Volumetric?
Volumetric apparteneva al batch Winter 2020 di Y Combinator.
Chi ha fondato Volumetric?
Volumetric è stato fondato da Jordan Miller, Bagrat Grigoryan.
Cosa fa Volumetric?
Volumetric builds living multicellular tissues with a focus on the…
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Volumetric, e di ogni altro batch YC, è in YC Insights.
Più startup YC come Volumetric
